The only centre in Spain
Drugs and doses suited to your genetics.
Time saving
Individual genetics and everyday business-related events, such as risky decision-making, nutritional imbalance, work conflicts, or family problems, become continuous threats to good brain function in executives and are triggers for many of their health problems.
Excess cholesterol and fats in the blood.
Cardiovascular diseases, associated with hyperlipidaemia and high blood pressure.
Cerebrovascular diseases and the risk of having a stroke or cerebrovascular accident from the age of 60 onwards.
Excessive eating and drinking which has a negative impact on liver function and increased transaminases.
Depressive disorders and anxiety, which contribute to emotional instability.
High blood pressure and associated risks.
Hyperglycaemia and type-II diabetes mellitus.
Cancer (lung, digestive, prostate, gynaecological, breast).
Programme for identifying the risk of Alzheimer's disease, or other forms of dementia, many years before the first symptoms appear. Allows discrimination of other memory disorders and dementias (vascular, mixed, fronto-temporal, Lewy body).
Alzheimer's disease has no curative treatment and current drugs (donepezil, rivastigmine, galantamine, memantine) are of limited efficacy in preserving memory and are not without toxicity. Work is underway on vaccines, but these will not be available for a decade, so the best form of intervention is considered to be preventive, intercepting the disease before it manifests itself through personalised intervention formulas.
If you would like to receive more information about our prevention plan for executives, you can arrange a free informative call with one of our team members who will answer all your questions.
He is one of the most internationally recognised Spanish scientists in diseases of the Central Nervous System, ageing and dementia, and a pioneer in Genomic Medicine and Pharmacogenomics. Editor of numerous scientific journals of international prestige, he is also President of the Spanish Society of Genomic Medicine and of the World Association of Genomic Medicine.
Pioneers in the worldwide implementation of Personalised Medicine based on knowledge of the human genome.
We are the first private company dedicated to the research, diagnosis, and treatment of diseases of the Central Nervous System. Our experience in this field of medicine makes us a leader in Spain and an international benchmark in Genomic Medicine and Pharmacogenetics, key disciplines for the prevention of multiple diseases, their early diagnosis, and the possibility of implementing personalised pharmacological treatment.